Eileen Joyce is Emeritus Professor of Neuropsychiatry at UCL Queen Square Institute of Neurology and an honorary consultant neuropsychiatrist at The National Hospital for Neurology and Neuropsychiatry. Her research has focused on interventions for neuropsychiatric disorders such as schizophrenia, OCD and Tourette’s syndrome and their mechanisms of action. Her clinic work has involved the management of complex neuropsychiatric disorders. She ran the National Tourette Clinic at NHNN for 15 years.

Professor Joyce obtained her first degree in experimental psychology and PhD in dopamine psychopharmacology from the University of Cambridge. She went on to study medicine also at Cambridge. She trained in psychiatry at the Bethlem and Maudsley Hospitals and spent several years as a research worker at the Institute of Psychiatry, where she was a Wellcome Trust Lecturer in Mental Health. This was followed by time at the USA National Institutes of Health. Before moving to UCL/UCLH, she was Professor of Neuropsychiatry at Imperial College. She has served as Chair of the British Neuropsychiatry Association, The Royal College of Psychiatry Faculty of Neuropsychiatry and the International Neuropsychiatric Association. She is currently a trustee of the charity Tourette’s Action.

Meher Lad is an NIHR Academic Clinical Lecturer in Neurology at Newcastle University. His clinical interests lie in cognitive neurology, especially young-onset and rare dementias, and autoimmune encephalitis. His research interests include characterising the relationship between the hearing brain and Alzheimer’s disease dementia using cognitive testing, neuroimaging and fluid biomarkers.

Dr Alex Lehn is a neurologist in Brisbane, Australia. He heads the movement disorder service at Princess Alexandra Hospital in Brisbane and together with Dr Sarah Olson he runs the deep brain stimulation service at PA Hospital and Mater Hospital Brisbane.

Dr Lehn has a keen interest in Functional Neurological Disorders (FND). He is a founding member and board member of the Functional Neurological Disorder Society. From 2015 to 2019 Dr Lehn headed a dedicated clinic for Functional Neurological Disorders at Mater Hospital Brisbane, the first such clinic in Australia. With his multidisciplinary team of health professionals, he runs regular teaching courses for FND across Australia and has published extensively in this area.

Sheldon Benjamin, MD is Professor of Psychiatry and Neurology at the University of Massachusetts T H Chan School of Medicine (UMass Chan), where he has served as Director of Neuropsychiatry since 1986. He served as Interim Chair of Psychiatry from 2017-2020, Director of the UMass Chan Neuropsychiatry Fellowship since 1989, founding director of the Combined Neurology/Psychiatry Residency Program from 1997-2020 (now associate director), and co-director of the UMass Chan fellowship in Adult Neurodevelopmental Disabilities. In 2020 he stepped down after 25 years as Psychiatry Program Director and is now Vice Chair for Education and Associate Program Director.

He had the pleasure of serving as Visiting Professor in Neuropsychiatry at Kings College Institute of Psychiatry, Psychology and Neuroscience from March-August 2023.

A graduate of the University of Cincinnati College of Medicine, he completed psychiatry residency training at Tufts New England Medical Center, neurology residency training at Tufts and Boston University, and fellowship in Behavioral Neurology at the Boston University/Boston Veterans Administration Hospital. He is board certified in both Psychiatry and Neurology (ABPN) and in Behavioral Neurology and Neuropsychiatry by the United Council on Neurological Subspecialties.

Dr. Benjamin is currently one of the Psychiatry Directors of the American Board of Psychiatry and Neurology. He has served as President of the American Association of Directors of Psychiatry Residency Training (AADPRT) and President of the American Neuropsychiatric Association (ANPA). He is a Distinguished Life Fellow of the APA, a Fellow of the American Academy of Neurology and a Fellow of ANPA.

Dr. Benjamin has been selected as the recipient of the Outstanding Educator Award by the Massachusetts Psychiatric Society, The UMass Chan Lamar Soutter Lifetime Achievement Award in Education, the UMass Chan Chancellors Medal for Distinguished Teaching, the American Neuropsychiatric Association’s Gary J Tucker, MD Lifetime Achievement Award in Neuropsychiatry, and the AADPRT Lifetime Service Award in Psychiatric Education.

A specialist in the evaluation of behavioral problems at the interface of psychiatry and neurology, he teaches clinical neuroscience and neuropsychiatry; and has published and presented widely on neuropsychiatry, clinical neuroscience training of psychiatrists; neurocognitive and neuropsychiatric examination techniques; educational technology; residency training issues; and the history of neuropsychiatry. He is co-author of The Brain Card®, a guide to comprehensive bedside neuropsychiatric examination; a coauthor of the ACGME-ABPN Psychiatry Milestones; a coauthor of the APA Guidelines for the Treatment of Schizophrenia, and a co-author of the forthcoming revision to the APA Guidelines for the treatment of Borderline Personality Disorder.

Perminder Sachdev AM MBBS MD FRANZCP PhD FAHMS is Scientia Professor of Neuropsychiatry, Co-Director of the Centre for Healthy Brain Ageing (CHeBA) in the School of Psychiatry, UNSW Sydney, and Clinical Director of the Neuropsychiatric Institute (NPI) at the Prince of Wales Hospital, Sydney, Australia. He is deputy chair of the Australian Dementia Network (ADNeT) and Director of the Centre of Research Excellence in Vascular Contributions to Dementia. His major areas of research are drug-induced movement disorders, brain imaging, cognitive ageing and dementia. He has published over 900 peer-reviewed journal papers and 6 books, including one for lay readers (The Yipping Tiger and other tales from the neuropsychiatric clinic) and a book of poems (A migrant’s musings). He was named NSW Scientist of the year for Biomedical Sciences in 2010. In 2011, he was appointed Member of the Order of Australia (AM) for services to medical research. In 2018, he won the DARF-Yulgilbar Innovation Award for dementia research. In 2022, he was awarded the Ryman Prize by an international jury for the most significant contributions world-wide toward the health of older people.

Position

• Professor for Psychiatry and Psychotherapy at the Albert-Ludwigs-University Freiburg
• Deputy Director of University Clinic for Psychiatry and Psychotherapy
• Head of Section for Experimental Neuropsychiatry

Fields of Special Clin. Interest

• neurobiology and psychotherapy of neurodevelopmental disorders (autism, ADHD, tic disorders and Gilles-de-la-Tourette syndrome
• neurobiology and therapy of organic and schizophrenia spectrum disorders

Fields of Research

• differential diagnosis, neurobiology and differential therapy of neurodevelopmental disorders (autism, ADHD, tic disorders)
• diagnosis and treatment of immunological encephalopathy and other organic variants of psychotic, affective and schizophreniform disorders
• Methodological focus: neuroimaging, neuroinflammation, visual neuroscience
• Theoretical medicine and philosophy: psychobiology of perception, thinking, emotion and behaviour; free will; intentional structure of metacognition

Academic achievements and awards

• Scholarship of the Cusanuswerk (1989 – 1995)
• Dissertation at the clinic of psychiatry of the university clinic Freiburg; »Neurobiology and Psychology of Depression« (1992-1995)
• Scholarship of the German Academic Exchange Service (DAAD); studies at the University of Manchester (1991-1992)
• Research scholarship of the Scientific Society of the University of Freiburg (Institute of Neurology, Queen Square, UCL, London; 1997 – 1998)
• Research Scholarship of the Raymond Way Neuropsychiatry Researchs Funds (Post-Doc; Institute of Neurology, Queen Square, UCL, London; 1997 – 1998)
• Gerok Scholarship of the University of Freiburg (set up of research lab for neuroimaging in psychiatry; 1998)
• Award of the British Neuropsychiatric Association (February 2000)
• Wilhelm Griesinger Award of the Berlin Societry for Neurology and Psychiatry (2002)
• Habilitation in Psychiatry and Psychotherapy: »On the pathophysiology of the amygdala and related frontobasal circuits in impuslive and emotional unstable syndromes« (2004)
• Call onto the list for Biological Psychiatry (C3) of the Humboldt University Berlin (2004)
• Call onto the chair for C3-Professorship (a.L.) for Psychiatry & Psychotherapy of the Heinrich-Heine-University Düsseldorf (2005, rejected)
• Call onto the chair Psychiatrie und Psychotherapie (W3, Ordinariat) of the Christian-Albrechts-University zu Kiel (2014, rejected)

Prof Aileen McGonigal is a Senior Staff Specialist in Neurology at Mater Hospital, Brisbane, Australia; Clinical Director of Epilepsy Unit, Mater Hospital, Brisbane; Honorary Professor, Mater Research Institute, Faculty of Medicine, University of Queensland; Affiliate Professor, Queensland Brain Institute, UQ.

She is a UK neurology-trained specialist with extensive experience gained in Marseille, France, an internationally renowned medical centre in epileptology and EEG, including stereo-EEG. She is board-certified in neurology in Australia, France and the UK. Her main research interests include topics in seizure semiology and its neural correlates based on stereo-EEG, on which she has written and lectured internationally. She also has an interest in neuropsychiatric aspects of epilepsy including psychological comorbidities. She is Editor-in-Chief of the Elsevier journal Neurophysiologie Clinique / Clinical Neurophysiology (NCCN), the official academic journal of the French Society of Clinical Neurophysiology. She is an active member of the International League Against Epilepsy, helping translate epilepsy research into improved patient care worldwide.

Dr Niraj Ahuja. Consultant Psychiatrist (General Adult Psychiatry).

MBBS, MD, FRCPsych, PG Cert ClinRes.

Regional Affective Disorders Service (RADS, a tertiary mood disorder service) at Campus for Ageing and Vitality (CAV), Newcastle.

Block Lead for 4th Year Medical Students, Sunderland Medical School.

Areas of interest: Mood disorders (including bipolar disorder and depression), Catatonia, Psychopharmacology.

Background

Dr Carson graduated in Medicine from Edinburgh University in 1991 and completed basic Psychiatry training at the Royal Edinburgh Hospital. Following six months as a Wellcome Research Fellow examining the cognitive effects of HIV infection in a Kenyan population, he was Lecturer and Honorary Senior Registrar in Psychiatry at University of Edinburgh.

During this time he developed his interest in neuropsychiatry and was trained by Professor Michael Sharpe, Professor David Owens and Professor Charles Warlow. He was subsequently appointed Consultant Neuropsychiatrist to Rehabilitation Medicine at the Astley Ainslie Hospital and to the Department of Clinical Neurosciences at the Western General Hospital.

He was an original grant holder for the development of the Scottish Mental Health Research Network.

Responsibilities & affiliations

• Associate Editor of Journal of Neurology, Neurosurgery and Psychiatry
• Previous Director – National Managed Clinical Network for Acquired Brain Injury
• Honorary Fellowship Royal College of Physicians Edinburgh
• Honorary Fellowship Royal College of Physicians Edinburgh
• Board of Directors – British Neuropsychiatry Association
• Editorial Board Member – Brain Injury (Journal of International Brain Injury Association)
• Co-editor Hallett M, Stone J, Carson A. Handbook of Neurology: Functional Symptoms
• Executive Board member – Neuropsychiatry Section, Royal College of Psychiatrists
• Royal College of Psychiatrists’ advisor on somatoform disorders for DSM V & ICD 11 revisions
• Scottish Government – Chair of writing group – General Practice Guidelines on CFS/ME
• Previous Chairman – Scottish Head Injury Forum
• Presidents Medal, Royal College of Psychiatrists (2017)

Jesús Ramírez-Bermúdez is a medical specialist in psychiatry and neuropsychiatry, having graduated from the National Institute of Neurology and Neurosurgery (INNN) of Mexico. Currently, he serves as a clinician and leads the program of neuropsychiatry and cognitive neurology at the same institution. Dr. Ramírez-Bermúdez holds a Doctorate in Sciences from the National University of Mexico. As a researcher, he focuses on the study of psychosis, catatonia, delirium, and autoimmune encephalitis, striving to integrate approaches from phenomenological psychopathology and cognitive neuropsychiatry. His contributions have garnered international recognition, in Australia (International Neuropsychiatric Association, 2006) and the United States (International Conference on Bipolar Disorders, 2011). Dr. Ramírez-Bermúdez has authored academic books dedicated to the clinical and scientific principles of neuropsychiatry, along with the clinical application of brain imaging. Actively involved in scientific outreach, literature, and cultural activities, he has published books that combine the elements of creative essay, scientific thought, and clinical narratives. He received the National Literary Essay Award by the Institute of Fine Arts in Mexico.

Dr Maria ( Meritxell ) Oto is a consultant neuro psychiatrist and the lead clinician at the Scottish Epilepsy Centre in Glasgow , which is the only residential centre for the assessment and management of epilepsy in Scotland. Dr Oto is also the lead clinician for the Liaison Psychiatry service in greater Glasgow and Clyde.

Dr Oto has been working in the field of epilepsy for most of her career; initially at the Institute of Neurology in Glasgow and thereafter at the Scottish Epilepsy Centre.

She obtained her medical degree at Barcelona University and completed her specialist training in the UK. In 2010 completed a Phd on the diagnosis and management of dissociative seizures which is one of her main research interest. She is involved in teaching locally and nationally amongst others participating on the ILAE uk registrars epilepsy teaching weekend and coordinates the epilepsy training of Intellectual disability trainees in Scotland

Dr Oto is also the chair of the epilepsy working group as well as the Scottish representative of the RCPsych neuropsychiatry faculty . She is a member of the ILAE UK council, a medical advisor of the charity Epilepsy Connections and a member if the editorial board of the European journal Seizure.

Professor Shoumitro (Shoumi) Deb, MBBS, FRCPsych, MD (s.deb@imperial.ac.uk), is a Visiting Clinical Professor of Neuropsychiatry at the Faculty of Medicine, Division of Brain Sciences at Imperial College London, UK. Previously, he was a full-time substantive Clinical Professor of Neuropsychiatry at the University of Birmingham and a Senior Clinical Lecturer at Cardiff University and the University of Aberdeen. His research interests include neuropsychiatry of Acquired Brain Injury (ABI), particularly apathy syndrome and aggressive behaviour following traumatic brain injury (TBI). His other research interests are epilepsy and intellectual disabilities (ID), dementia and Down’s syndrome. His current work is on the psychopharmacology of aggression in people with TBI and adult neurodevelopmental disorders (NDDs). He has also done some preliminary work on advanced neuroimaging (VBM, DTI, fMRI, EEG-fMRI, MRS, etc.), particularly in the context of social cognitive impairment in TBI. He has over 345 publications, including 12 books and over 60 book chapters and made over 250 presentations at national and international conferences (including keynote speeches and chairing of sessions). His citation index is 9670, the h-index is 52, and the i10 index is 145 (28.07.24). He has received research funding from the UK Department of Health, NIHR, the Welsh Office of R&D, the Wellcome Trust, and other charities. He led a research and teaching team of over 20 members at the University of Birmingham. He was the Programme Director for the MSc course on Psychological Medicine at Cardiff University and the MSc in Epilepsy at the University of Birmingham. He was also the module coordinator for the MSc in Neuropsychiatry and Intellectual Disabilities at the University of Birmingham. His research has always involved patients and their caregivers from the outset, helped improve their quality of life, improved services for patients and carers, and has been used as evidence in the UK NICE guidelines and NIHR.

His seminal work includes (a) the first-ever comprehensive neuropsychiatric outcome study of adults with traumatic brain injury (TBI) (AJP, 1999) https://doi.org/10.1176/ajp.156.3.374, (b) patient and carer-determined outcome measures including neurobehavioral and neurocognitive assessments for patients with TBI and their carers/caregivers (HIPS + HINAS and CHIPS + CHINAS) (NDT, 2007) https://www.tandfonline.com/doi/full/10.2147/ndt.s12160185, (c) the only published RCT (feasibility) on risperidone versus placebo to treat aggression in adults with TBI (BMJO, 2020) https://doi.org/10.1136/bmjopen-2019-036300, (d) lead of national and international guidelines on the use of psychotropic medications in adults with intellectual disabilities (ID) for behaviours that challenge (World Psychiatry, 2009) https://doi.org/10.1002/j.2051-5545.2009.tb00248.x, (e) the first-ever comprehensive assessment of psychopathology in adults with ID and epilepsy (BJP, 1991) https://doi.org/10.1192/bjp.159.6.822, (f) the first ever comprehensive assessment of psychiatric disorders in adults with ID (JIDR, 2001) https://doi.org/10.1046/j.1365-2788.2001.00374.x, (g) a dementia screening questionnaire for adults with ID (DSQIID) translated into more than 24 languages and validated for worldwide use (BJP, 2007) https://doi.org/10.1192/bjp.bp.106.024984, (h) the first-ever freely available online accessible (easy read) psychotropic medication information leaflets http://www.ld-medication.bham.ac.uk,  (i) the first-ever European Guideline (and recent update in EJP, 2022) on the assessment and diagnosis of psychiatric disorders in adults with ID https://doi.org/10.1016/j.ejpsy.2021.10.002, (j) the first-ever online training, SPECTROM for caregivers to help reduce the overmedication of people with ID https://spectrom.wixsite.com/project,  (k) the first-ever evidence-based practice guidelines for ID in the UK NHS.

Jane Alty is an Associate Professor of Neurology at the University of Tasmania and a Neurologist at the Royal Hobart Hospital. She sub-specialises in cognitive neurology and movement disorders. She is the Director of the ISLAND Clinic in Tasmania, a one-stop state-wide clinic that provides an interdisciplinary cognitive assessment and diagnosis. She is also a lead investigator on the ISLAND Project, a 10-year public health initiative to reduce dementia risk, comprising ~14,000 participants and the elected secretary of the Australasian Cognitive Neurological Association. Her research investigates Artificial Intelligence methods to detect the preclinical stages of Alzheimer’s and Parkinson’s disease, funded through the NHMRC and MRFF.

Jonathan Rogers is a Clinical Lecturer in the Division of Psychiatry at University College London. His research interests include catatonia, neuroimmunology, psychopharmacology and movement disorders more broadly.

He studied Medicine at the University of Cambridge and subsequently trained in Psychiatry as an NIHR Academic Clinical Fellow at the Maudsley Hospital and King’s College London. He is currently a Specialty Registrar in Neuropsychiatry at the National Hospital for Neurology and Neurosurgery, London.

His work has been reported widely in the media and he has been awarded prizes from the Royal College of Psychiatrists, the British Neuropsychiatry Association and the British Association for Psychopharmacology.

Vaughan Bell is a professor of clinical psychology and cognitive neuropsychiatry at University College London. He is also a neuropsychologist working between psychosis and neuropsychiatry services at the Maudsley Hospital in London. He completed his PhD on the cognitive neuropsychiatry of psychosis before completing a DClinPsy in clinical psychology. He currently leads the neuropsychology teaching on the doctorate in clinical psychology at UCL. As a researcher, he has a particular interest in secondary syndromes of psychosis, mental health outcomes of neurological disorders, and frequently collaborates with colleagues in Latin America. Vaughan is also the co-editor of the journal Cognitive Neuropsychiatry.

vaughan.bell@ucl.ac.uk

David L. Perez MD, MMSc, FAAN, FANPA, FAPA, FANA is board certified in Neurology, Psychiatry, and Behavioral Neurology & Neuropsychiatry, and is a full-time faculty member in the Mass General Brigham Departments of Neurology and Psychiatry. At Harvard Medical School, Dr. Perez is an Associate Professor of Neurology and an Associate Professor of Psychiatry. Dr. Perez is the Chief of the Mass General Brigham Division of Behavioral Neurology. He is also the Founding Director of the multidisciplinary Functional Neurological Disorder (FND) Unit and FND Research Group. Dr. Perez has published over 150 articles – the majority in the fields of functional neurological disorder, brain imaging research, and behavioral neurology & neuropsychiatry. He has co-edited two textbooks on functional neurological disorder – including a 32-chapter Springer Functional Movement Disorder textbook. Dr. Perez is affiliated with the MGH/HST Athinoula A. Martinos Center for Biomedical Imaging and the Center for Brain/Mind Medicine.

W Curt LaFrance Jr, MD, MPH, FAAN, FANPA, DLFAPA, FAES is professor of psychiatry and neurology at Brown University Alpert Medical School and runs the neuropsychiatry and behavioral neurology clinic at Rhode Island Hospital. He is Director of the VA Mind Brain Program, Program Director for VA National Expert Consultation & Specialized Services Neuropsychiatry Clinic, and staff physician at the Providence VAMC. He studied at Wake Forest University (B.A. in Psychology), Medical College of Georgia (M.D.) and Brown University (MPH).

He trained in Brown’s combined neurology/psychiatry residency and is double boarded. He is the International League Against Epilepsy (ILAE) Neuropsychiatry Commission Chair and has chaired ILAE and American Epilepsy Society NES Task Forces. He has served on the EFA and EFNE Professional Advisory Boards. He has received grants from EF, AES, Foundations, Veterans Affairs, DoD, and a NINDS K23 Award. He trains clinicians around the country using distance supervision in neurobehavioral therapy (NBT), used for seizures, movement disorders, cognitive and somatic symptom disorders, based on a whole-person, integrative medicine biopsychosocial spiritual approach. His research focuses on developing new biomarkers and treatments for neuropsychiatric aspects of epilepsy, conversion (functional neurological) disorders and TBI. He is co-editor of “Nonepileptic Seizures”, 4th ed., and co-author of “Taking Control of Your Seizures: Workbook” and “Taking Control of Your Seizures: Therapist Guide.” A goal of his work at Brown, nationally and internationally, has been to bridge neurology and psychiatry clinical practice and scientific research and to dissolve arbitrary boundaries between the two fields.

Richard Davenport is a Consultant Neurologist and Honorary Senior Lecturer in Edinburgh, appointed in 1999. After graduating from the University of Nottingham in 1987, he completed general medical training in Stoke-on-Trent, moved to Edinburgh in 1992, and after a DM thesis in stroke, spent a year in Western Australia as senior neurology trainee, before returning to Edinburgh as one of the last UK Senior Registrars. He is a general neurologist, as well as running first seizure, movement disorders, and MND clinics. He was elected to the Association of British Neurologists Council in 2009, appointed Chair of the Training and Education committee in 2010, demitting in 2016. In 2019 he was appointed ABN Meetings secretary and in April 2021 elected President Elect of the ABN, completing his Presidential term 2023-25.

He was Chair of the National Advisory Committee for Neurological Conditions (Scotland) for 3 years from 2017 and Specialty Advisor to Chief Medical Officer (Neurology) 2017-2023. Reflecting his interest in education and training, he was on the standard setting boards for the MRCP Specialty Certificate Examination (SCE) for Neurology for many years, secretary of Neurology SCE exam board until 2022 and member of the MRCP part 1 exam board 2017-2019. He organises and chairs the annual Edinburgh Neurology Course, and leads weekly local neurology trainee teaching, including neurology book clubs. Outside of neurology, he cycles shorter distances ever more slowly; any disposable income not wasted on faster bikes and kit is gratefully absorbed by various Edinburgh Art dealers.

International expert in behavioural neurology and neuropsychiatry with 29 years of clinical specialty experience. Immediate Past President of the International Neuropsychiatric Association with multiple current and past leadership roles in clinical science & academia. Healthcare entrepreneur, social impact leader, speaker, editor, writer and medical personality based in Chennai, India.

founder@buddhiclinic.com

Sigita Plioplys, MD, is the Head of the Pediatric Neuropsychiatry Program at the Pritzker Department of Psychiatry and Behavioral Sciences and a consultant psychiatrist at the Epilepsy Center at Lurie Children’s Hospital of Chicago, Professor of Psychiatry in the Department of Psychiatry of Feinberg School of Medicine, Northwestern University in Chicago. Her clinical expertise involves psychiatric disorders of children with neurological disorders, specifically epilepsy. She is a world-renowned expert in pediatric psychogenic nonepileptic seizures and Functional Neurological Disorders (FND). She has been involved in developing national and international educational, clinical, and research initiatives for mental health care for children with FND. She had received private and federal grants for research and has published consistently for the past 25 years in pediatric neuropsychiatry, specifically psychogenic nonepileptic seizures. In 2024, Dr. Plioplys has received a prestigious AACAP Simon Wile award for Leadership in Pediatric CL. She has authored and coauthored over 50 articles and 12 book chapters, including the first case-controlled study on the risk factors for pediatric psychogenic non-epileptic seizures. She had held leadership positions as a co-chair of Physically Ill Child Committee at AACAP, PNES Committee at the American Epilepsy Society.

Dr. Margo Lauterbach, MD, FANPA, DFAPA, is a neuropsychiatrist with experience in both clinical practice and academia. She is currently the Director of the Concussion Clinic at Sheppard Pratt in Maryland, USA, and she is also part of the research team at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics studying psychedelics.

Dr. Lauterbach is board-certified in the subspeciality of Behavioral Neurology & Neuropsychiatry. She completed her medical degree at Flinders University of South Australia and her residency training and neuropsychiatry fellowship at the University of Massachusetts Medical School. Dr. Lauterbach is actively involved several professional organizations, including American Neuropsychiatric Association (ANPA) where she currently serves as Treasurer, the Group for the Advancement of Psychiatry (GAP) on the Neuropsychiatry Committee, the American Board of Psychiatry and Neurology (ABPN), and the American College of Psychiatrists.

Dr. Lauterbach’s academic interests encompass traumatic brain injury, rare disorders, medical education, neurotoxicology and psychedelics. Dr. Lauterbach has contributed significantly to the field through teaching at all levels, numerous publications, research projects, and presentations at national and international conferences.